Why is Alpha Cognition stock surging today?

Alpha Cognition (NASDAQ:ACOG) said ZUNVEYL demand rose each month in Q2, with June the strongest month to date, and management attributed growth to demand rather than wholesaler or pharmacy stocking. Payer formulary activation lagged expectations, with payer access the key near-term friction. The company reported BEACON study positive top-line results, lowered 2026 operating expense guidance to $50M-$54M, and had $41.4M cash as of June 30.

Alpha Cognition (NASDAQ: ACOG) reported Q2 2026 results for ZUNVEYL. Net product revenue rose about 71% QoQ to $6.0M. Bottles dispensed increased 37% to 8,294, with June monthly demand at 2,997. Cash and cash equivalents were $41.4M at June 30. The company cut full-year 2026 R&D and SG&A guidance to $50–$54M.

Alpha Cognition Inc. (NASDAQ: ACOG) said the European Patent Office granted a European patent covering a crystalline solid form of benzgalantamine, the active ingredient in ZUNVEYL, for use in treating mild-to-moderate Alzheimer’s disease. The patent covers specific solid form, compositions, manufacturing and medical-use claims, with potential protection into 2042, subject to requirements.

Stratasys reported Q2 2026 results on an earnings call, citing record quarterly consumables revenue and growth in Aerospace and Defense (+17% YoY) and Stratasys Direct (+12.1%). The company reaffirmed full-year 2026 guidance, expects higher system sales in H2, and said the MarkForged acquisition should add to EBITDA within a year. Cash flow outlook was affected by non-routine IP litigation expenses.

AIRO held its Q2 2026 earnings call, saying it delivered Q2 revenue above expectations, with gross margin improving to 64% and a swing to a small operating profit. The company reiterated full-year revenue growth guidance of 15% to 25% and reported drone backlog up about 9% to ~$163 million. It also cited Blue UAS certification for the RQ-35 and progress on RQ-70 and JC250/JX250.

Xunlei (XNET) reported Q2 2026 results in an earnings call transcript. Total revenue rose to $102.7 million, up 38.9% year over year, driven by subscription revenue of $44.5 million (+22.6%) and overseas audio live streaming revenue of $58.2 million (+54.8%). Gross margin fell to 55.8% from 63%. The company announced a $20 million share repurchase program.